These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1562864)

  • 1. Decreased 5-HT-mediated prolactin release in major depression.
    Anderson IM; Ware CJ; da Roza Davis JM; Cowen PJ
    Br J Psychiatry; 1992 Mar; 160():372-8. PubMed ID: 1562864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V; McLoughlin D; Dinan TG
    J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clomipramine enhances prolactin and growth hormone responses to L-tryptophan.
    Anderson IM; Cowen PJ
    Psychopharmacology (Berl); 1986; 89(1):131-3. PubMed ID: 3016787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.
    Golden RN; Ekstrom D; Brown TM; Ruegg R; Evans DL; Haggerty JJ; Garbutt JC; Pedersen CA; Mason GA; Browne J
    Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism.
    George DT; Nutt DJ; Rawlings RR; Phillips MJ; Eckardt MJ; Potter WZ; Linnoila M
    Biol Psychiatry; 1995 Jan; 37(2):112-9. PubMed ID: 7718674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
    Williamson DJ; McTavish SF; Park SB; Cowen PJ
    Br J Psychiatry; 1995 Aug; 167(2):238-42. PubMed ID: 7582676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.
    Heninger GR; Charney DS; Sternberg DE
    Arch Gen Psychiatry; 1984 Apr; 41(4):398-402. PubMed ID: 6703856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs.
    Price LH; Charney DS; Delgado PL; Goodman WK; Krystal JH; Woods SW; Heninger GR
    J Clin Psychiatry; 1990 Apr; 51 Suppl():44-50; discussion 51-2. PubMed ID: 2182616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression. Depressed vs normal children.
    Ryan ND; Birmaher B; Perel JM; Dahl RE; Meyer V; al-Shabbout M; Iyengar S; Puig-Antich J
    Arch Gen Psychiatry; 1992 Nov; 49(11):843-51. PubMed ID: 1444721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients.
    Golden RN; Hsiao JK; Lane E; Ekstrom D; Rogers S; Hicks R; Potter WZ
    Psychiatry Res; 1990 Jan; 31(1):39-47. PubMed ID: 2156276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal neuroendocrine responsivity to clomipramine in depression.
    Golden RN; Ruegg R; Brown TM; Haggerty J; Garbutt JC; Pedersen CA; Evans DL
    Psychopharmacol Bull; 1990; 26(3):317-20. PubMed ID: 2125736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonergic function in endogeneity of depression].
    González-Pinto A; López-Ibor JJ; Sáiz J; Gutiérrez M; Figuerido JL; Elizagárate E; Pérez de Heredia JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):73-8. PubMed ID: 9245192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin function in affective disorders.
    Grahame-Smith DG
    Acta Psychiatr Scand Suppl; 1989; 350():7-12. PubMed ID: 2683591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet serotonin markers and depressive symptomatology.
    Sheline YI; Bardgett ME; Jackson JL; Newcomer JW; Csernansky JG
    Biol Psychiatry; 1995 Apr; 37(7):442-7. PubMed ID: 7786957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blunted growth hormone and prolactin responses to L-tryptophan in depression; a state-dependent abnormality.
    Upadhyaya AK; Pennell I; Cowen PJ; Deakin JF
    J Affect Disord; 1991 Mar; 21(3):213-8. PubMed ID: 1829742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin in patients with major depressive disorder and in healthy subjects. II. Longitudinal study of basal prolactin and post-TRH-stimulated prolactin levels.
    Baumgartner A; Gräf KJ; Kürten I
    Biol Psychiatry; 1988 Jul; 24(3):268-85. PubMed ID: 3135848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium increases 5-HT-mediated prolactin release.
    McCance SL; Cohen PR; Cowen PJ
    Psychopharmacology (Berl); 1989; 99(2):276-81. PubMed ID: 2508166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal 5-HT1D receptor function in major depression: a neuropharmacological challenge study using sumatriptan.
    Cleare AJ; Murray RM; Sherwood RA; O'Keane V
    Psychol Med; 1998 Mar; 28(2):295-300. PubMed ID: 9572087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.